Literature DB >> 9298880

Gastric graft-versus-host disease: a blinded histologic study.

K Washington1, R C Bentley, A Green, J Olson, W R Treem, H R Krigman.   

Abstract

Acute graft-versus-host disease (GvHD) of the upper gastrointestinal (GI) tract is common after allogeneic bone marrow transplantation (BMT). However, diagnosis cannot be made on clinical presentation and endoscopic findings alone, because these are nonspecific, and histologic confirmation is often desirable. The diagnosis of gastric GvHD is often based on subtle findings with considerable potential for variability in interpretation. Evaluation of the reproducibility of diagnosis and recognition of histologic features of gastric GvHD was based on blinded review of 56 gastric biopsies (24 from patients with allogeneic BMT or unrelated umbilical cord blood transplantation and 32 control biopsies from patients who did not undergo BMT, of whom eight had active GI cytomegalovirus [CMV] infection). Histologic criteria for GvHD were apoptosis and gland destruction, sparse inflammatory infiltrate, and granular eosinophilic debris in dilated glands. Seventeen patients (22 biopsies) were judged to have clinical GvHD on the basis of skin or liver involvement and GI symptoms without other known cause. Eighteen of these 22 gastric biopsies were classified as GvHD by at least two of the three pathologists on initial review. Blinded histologic diagnosis of GvHD had a positive predictive value of 69%, a sensitivity of 82%, and specificity of 76%. False-positive results occurred in CMV gastritis, human immunodeficiency virus (HIV) infection, primary immunodeficiency, and after renal transplantation. Of individual features, granular debris in glands was a specific (94% specificity), but insensitive (41% sensitivity) marker for GvHD. Distinction between GvHD and CMV infection can be difficult, and GvHD can be confused with changes seen in HIV infection and other immunodeficiency states.

Entities:  

Mesh:

Year:  1997        PMID: 9298880     DOI: 10.1097/00000478-199709000-00008

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

Review 1.  [Histopathology of graft-versus-host disease].

Authors:  F Länger; F Puls; S Buchholz; C Loddenkemper; A Ganser; H Kreipe
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

2.  Histologic analysis has a prognostical value in colorectal biopsies assessed for suspicion of graft-versus-host disease.

Authors:  Fanny Sauvestre; Geneviève Belleannée; Claire Bréal; Catherine Mohr; Harold IpKan Fong; Sébastien Cossin; Reza Tabrizi; Noël Milpied; Stéphane Vigouroux; Jean-François Goussot; Marion Marty
Journal:  Virchows Arch       Date:  2017-11-22       Impact factor: 4.064

3.  Graft-versus-Host Disease of the Gut: A Histologic Activity Grading System and Validation.

Authors:  David Myerson; Gideon Steinbach; Ted A Gooley; Howard M Shulman
Journal:  Biol Blood Marrow Transplant       Date:  2017-05-19       Impact factor: 5.742

4.  18F-FDG PET/CT for the assessment of gastrointestinal GVHD: results of a pilot study.

Authors:  C Bodet-Milin; M Lacombe; F Malard; E Lestang; X Cahu; P Chevallier; T Guillaume; J Delaunay; E Brissot; P Moreau; F Kraeber-Bodere; M Mohty
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

5.  Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility.

Authors:  Andreas Kreft; Anja Mottok; Ildiko Mesteri; Diana M Cardona; Anne Janin; Anja A Kühl; Mindaugas Andrulis; Andrea Brunner; Howard M Shulman; Giovanni Negri; Alexandar Tzankov; Elisabeth Huber
Journal:  Virchows Arch       Date:  2015-07-12       Impact factor: 4.064

Review 6.  Pathology of non-Helicobacter pylori gastritis: extending the histopathologic horizons.

Authors:  Gregory Y Lauwers; Hiroshi Fujita; Koji Nagata; Michio Shimizu
Journal:  J Gastroenterol       Date:  2009-12-05       Impact factor: 7.527

Review 7.  The role of oral beclometasone dipropionate in the treatment of gastrointestinal Graft-versus-Host Disease.

Authors:  Phuong L Doan; Nelson J Chao
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

Review 8.  The differential diagnosis of Helicobacter pylori negative gastritis.

Authors:  Hala El-Zimaity; Won-Tak Choi; Gregory Y Lauwers; Robert Riddell
Journal:  Virchows Arch       Date:  2018-09-25       Impact factor: 4.064

9.  Use of the National Institutes of Health Consensus Guidelines Improves the Diagnostic Sensitivity of Gastrointestinal Graft-Versus-Host Disease.

Authors:  Diana M Cardona; Claire J Detweiler; Michael J Shealy; Anthony D Sung; Daniel M Wild; Martin H Poleski; Bryan L Balmadrid; Constance T Cirrincione; David N Howell; Keith M Sullivan
Journal:  Arch Pathol Lab Med       Date:  2018-04-26       Impact factor: 5.534

10.  Monosomies 7p and 12p and FLT3 internal tandem duplication: possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution.

Authors:  Yosuke Matsumoto; Tomohiko Taki; Yoshiko Fujimoto; Kyoko Taniguchi; Daisuke Shimizu; Kazuho Shimura; Hitoji Uchiyama; Junya Kuroda; Kenichi Nomura; Tohru Inaba; Chihiro Shimazaki; Shigeo Horiike; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.